ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
3.020
+0.070 (2.37%)
Nov 4, 2024, 4:00 PM EST - Market closed
ADC Therapeutics Employees
As of December 31, 2023, ADC Therapeutics had 274 total employees, including 273 full-time and 1 part-time employees. The number of employees decreased by 43 or -13.56% compared to the previous year.
Employees
274
Change (1Y)
-43
Growth (1Y)
-13.56%
Revenue / Employee
$243,599
Profits / Employee
-$784,332
Market Cap
292.00M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 274 | -43 | -13.56% |
Dec 31, 2022 | 317 | 5 | 1.60% |
Dec 31, 2021 | 312 | 104 | 50.00% |
Dec 31, 2020 | 208 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Zynex | 1,100 |
Cerus | 637 |
uniQure | 480 |
Sutro Biopharma | 302 |
Personalis | 225 |
Lyell Immunopharma | 224 |
Fate Therapeutics | 181 |
Genfit | 159 |
ADCT News
- 10 hours ago - ADC Therapeutics to Present at November Investor Conferences - PRNewsWire
- 3 days ago - ADC Therapeutics Makes Grants to New Employees Under Inducement Plan - PRNewsWire
- 4 days ago - ADC Therapeutics to Host Third Quarter 2024 Financial Results Conference Call on November 7, 2024 - PRNewsWire
- 2 months ago - ADC Therapeutics to Present at Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - ADC Therapeutics SA (ADCT) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - ADC Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update - GlobeNewsWire
- 3 months ago - ADC Therapeutics to Host Second Quarter 2024 Financial Results Conference Call on August 6, 2024 - GlobeNewsWire
- 4 months ago - Myricx Bio Announces £90m ($114m) Series A Financing to Advance its Novel NMTi-ADC Therapeutics into Clinical Development - GlobeNewsWire